Editorial Board Member - JSCCP
Nils Ole Schmidt
NeurosurgeonDepartment of Neurosurgery
University Medical Center Hamburg-Eppendorf
Germany
BIOGRAPHY:
Dr. Nils Ole Schmidt is a senior attending neurosurgeon at the Department of Neurosurgery at the University Medical Center Hamburg-Eppendorf in Germany with a clinical focus on neuro-oncological and cerebrovascular surgery. He is head of a research group within the Hans-Dietrich Herrmann Laboratory for Brain Tumor Biology. He graduated from Medical School at the University of Hamburg with several clinical internships in the UK, USA, Switzerland and South Africa. He did his postdoctoral training in the Neurosurgical Oncology Laboratory at the Department of Neurosurgery, Brigham & Women‘s Hospital/Children’s Hospital, Harvard Medical School in Boston, USA and completed his neurosurgical specialization in Hamburg.
RESEARCH INTERESTS:
Dr. Nils Ole Schmidt‘s research aims for the development of targeted brain tumor therapies with a major focus on stem cell technology, drug delivery, gene therapy, tissue engineering, angiogenesis and MR imaging.
Other Editorial Board Members - JSCCP
Massimo Dominici
Head Laboratory of Cell Biology and Advanced Cancer Therapies
Department of Medical and Surgical Sciences for Children & Adults
University Hospital of Modena and Reggio Emilia
Italy
Marc Poirot
Cancer Research Center of Toulouse
University of Toulouse
France
Kiminobu Sugaya
Burnett School of Biomedical Sciences
College of Medicine
University of Central Florida
United States
Bodo-Eckehard Strauer
Department of Cardiology
University of Duesseldorf
Germany
Ren-Ke Li
Laboratory Medicine and Pathobiology
University of Toronto
Canada
Abdolreza Esmaeilzadeh
Department of Immunology
Cancer Gene Therapy Research Center
Zanjan University of Medical Sciences
Iran
Arvind Chhabra
Department Of Medicine
University of Connecticut Health Center
United States
Xiaoming Yang
Department of Radiology
University of Washington School of Medicine
United States
Bonghee Lee
Lee Gil Ya Cancer and Diabetes Institute
Gachon University
Korea
Eva Mischak-Weissinger
Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation
Hannover Medical School
Germany